Schedule 13G ownership disclosure
CB Pharma Acquisition Corp.
Security class unavailable · CUSIP: G2029P126
Event date: 2015-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 350,000
- Percent of class
- 6.3200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-16-003304
- Form type
- SC 13G
- Filer
- AQR CAPITAL MANAGEMENT LLC
- CIK
- CIK 1167557
- Filed
- Feb 16, 2016
- Reporting period
- Dec 31, 2015
- Description
- Schedule 13G beneficial ownership